We observed statistically lower Her2 mRNA blood levels for Her2- patients when compared to Her2+ group, in accordance to previous studies which showed that blood Her2 expression correlates with Her2 levels in tumor cells [23], [24]. Here, ERBB2 is linked to neoplasm.